Evidence map›Paper›PMID 37415074›Full record

ArticleScientific reports2023

A model eye for fluorescent characterization of retinal cultures and tissues.

G Ferraro, Y Gigante, M Pitea, L Mautone, G Ruocco, S Di Angelantonio, M Leonetti

Abstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

G FerraroCenter for Life Nano- & Neuro-Science , Istituto Italiano di Tecnologia, Viale Regina Elena, 291, 00161, Rome, Italy.
Y GiganteCenter for Life Nano- & Neuro-Science , Istituto Italiano di Tecnologia, Viale Regina Elena, 291, 00161, Rome, Italy.
M PiteaCenter for Life Nano- & Neuro-Science , Istituto Italiano di Tecnologia, Viale Regina Elena, 291, 00161, Rome, Italy.
L MautoneCenter for Life Nano- & Neuro-Science , Istituto Italiano di Tecnologia, Viale Regina Elena, 291, 00161, Rome, Italy.
G RuoccoCenter for Life Nano- & Neuro-Science , Istituto Italiano di Tecnologia, Viale Regina Elena, 291, 00161, Rome, Italy.
S Di AngelantonioCenter for Life Nano- & Neuro-Science , Istituto Italiano di Tecnologia, Viale Regina Elena, 291, 00161, Rome, Italy. silvia.diangelantonio@uniroma1.it.
M LeonettiCenter for Life Nano- & Neuro-Science , Istituto Italiano di Tecnologia, Viale Regina Elena, 291, 00161, Rome, Italy. marco.leonetti@cnr.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many human neural or neurodegenerative diseases strongly affect the ocular and retinal environment showing peculiar alterations which can be employed as specific disease biomarkers. The noninvasive optical accessibility of the retina makes the ocular investigation a potentially competitive strategy for screening, thus the development of retinal biomarkers is rapidly growing. Nevertheless, a tool to study and image biomarkers or biological samples in a human-like eye environment is still missing. Here we report on a modular and versatile eye model designed to host biological samples, such as retinal cultures differentiated from human induced pluripotent stem cells and ex-vivo retinal tissue, but also suited to host any kind of retinal biomarkers. We characterized the imaging performance of this eye model on standard biomarkers such as Alexa Fluor 532 and Alexa Fluor 594.

Indexed as

Induced Pluripotent Stem CellsBiomarkersCell DifferentiationHumansRetinaBiomarkers

Identifiers

PMID37415074
PMCPMC10326009

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.